Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. - Wikidata - awgldk - TriplyDB

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

http://www.wikidata.org/entity/Q33780866

about

Methods for diagnosis of bile acid malabsorption in clinical practice Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome Review article: bile acid diarrhoea - pathogenesis, diagnosis and management Planar cell polarity genes control the connectivity of enteric neurons.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Colonic transit time and IBS symptoms: what's the link?Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy Recent advances in pharmacological treatment of irritable bowel syndrome.Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.American Gastroenterological Association technical review on constipation.Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome: a population-based survey in China Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea.Validating biomarkers of treatable mechanisms in irritable bowel syndrome What is necessary to diagnose constipation?Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea.Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis.Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders.Scintigraphic biomarkers for colonic dysmotility.Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders.Classification of functional dyspepsia based on concomitant bowel symptoms Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.Interpretation of overall colonic transit in defecation disorders in males and females.Chronic Constipation and Constipation-Predominant IBS: Separate and Distinct Disorders or a Spectrum of Disease?Evaluating the safety and the effects on colonic compliance of neostigmine during motility testing in patients with chronic constipation.Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation.Regional Colonic Transit Pattern Does Not Conclusively Identify Evacuation Disorders in Constipated Patients with Delayed Colonic Transit A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation.Behavioural and new pharmacological treatments for constipation: getting the balance right The clinical significances of irritable bowel syndrome in Taiwan.The bile acid TGR5 membrane receptor: from basic research to clinical application.Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or 'psychomarkers'?Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?

P2860

Q24618216-ABD08B92-1753-4C20-A155-B1119DC23A4B Q24635181-03D67109-46C9-4F72-AD6B-ECEA9484ABF2 Q26765272-56911121-3646-4D67-BC07-DBD975C6C468 Q28273649-23B4D217-616C-47CA-AC8D-20E0D30A8B41 Q30538290-9ED44D6E-97FB-408A-AFB7-C08DA0EA7202 Q33451900-9B6442C8-511D-43A2-9243-33A3C235386B Q33453362-D790BC07-3B5D-473B-80D5-478473BFB60F Q33958808-4460574C-BA29-4347-8994-9AC6F0BDE8BB Q33958853-F77C8C7C-B0AE-4991-B163-74D8A737EF5E Q34131127-7EB11C31-A231-4478-B700-128EB928BC23 Q34269632-74C73803-EA5E-4CE4-A6CB-3944636BE612 Q34319119-CD72801D-433B-4018-A866-92A160BC34C2 Q34399377-D369D1D3-F597-4D48-84DD-D74D072E9A8F Q34436504-E84402A0-3A5C-445B-BC9E-C0B2BBD6BA6A Q34577283-585EC964-6799-41A0-A718-5100A8A084C7 Q34627402-A5DA2CF5-A32C-41FB-A416-3C4F5EAE6A2F Q34907508-F10F4BBA-770D-417A-AFBC-0068F2BAA784 Q34949021-95580870-6560-47BB-8129-CB8D87E0FC9D Q35028313-BEC98BDD-ED99-4110-85DD-83731D96242D Q35214374-6C0F44C7-77BA-41C5-9BB8-68221D2BD403 Q35244325-B1DE89D9-13D4-4A03-8D94-B4FFD1655877 Q35309093-C034047A-6A37-4B6D-849E-C1E45CE9D1C4 Q35384517-3E1707E2-C3FF-40A5-BE49-ED9943A51674 Q36021269-848AC6B9-3DFE-4AB7-A3F6-22EF679154BF Q36067256-08F4447C-782B-4875-BB28-D30B71F438D2 Q36379093-9A1EF03F-EA32-45B7-950C-DACCCA5C5924 Q36494385-3DAA0416-AD33-4974-BDC3-F507620A1220 Q36849925-E7E9DD7E-ABE2-46D1-BB57-08B284A491AB Q36916631-05852FC5-A985-4843-BEC4-899D59D17E8F Q36927667-AF55FEB6-4A96-4FE4-93C6-13E94DDAF5AC Q36970524-547110B8-3037-47A6-B3DB-1411B1E4F379 Q37270032-CE43C09D-987A-4DF1-AE68-A7FF02A18971 Q37564153-47057207-0A36-47EC-9373-CD62003D36B8 Q37585280-855D5DE5-B1E4-4B87-96C1-65B13E921484 Q37783838-4AB28372-A153-4B0D-AD08-854F426D1934 Q37858649-9C0C4E4E-461C-44C0-AC49-67C729AD293C Q38177434-EB0AA93E-7376-4C0B-A1C7-E9816388AD19 Q38234705-EA8B0356-B99F-417C-A3FC-A6B773C82418 Q38528017-707E82A0-7BA5-4671-87F7-287743E5E1AF Q38765085-1DD47462-0B25-4786-B303-6DD4846EC3E6

P2860

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

http://www.wikidata.org/entity/Q33780866

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@ast

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@en

type

label

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@ast

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@en

prefLabel

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@ast

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@en

P1433

Q33780866-2E4E57C0-5261-496D-8087-8151EB2FB0A1

P1476

Q33780866-62FFB67C-D237-4A42-B4A9-BDF77BA0C2C0

P2093

Q33780866-18B664D5-89A2-4F44-8361-EA573749CE59

Q33780866-398A7D10-996A-44A3-B1A3-FFFD9C402080

Q33780866-5A883AB7-46FF-4BA5-B753-92208836188A

Q33780866-64C53F4C-C374-4215-8A74-BB249FB1D593

Q33780866-D8E86DF7-E08A-4EDF-A40C-F2AB503B95EA

P2860

Q33780866-0A4DDC25-B522-4249-9376-7438DA0B6F42

Q33780866-0D627185-15A6-45CB-BA68-A3D5774C6CC2

Q33780866-0E55BD46-0F17-4F2D-8CA9-0358655A2C28

Q33780866-1104B98A-AC5C-441D-ADF2-9C014823A58D

Q33780866-14194AB3-356D-4510-91B1-295689F817FF

Q33780866-2087322C-9179-4E5E-999D-CCCFEA465305

Q33780866-2B07107F-8F68-4B24-9709-AD62926F7A65

Q33780866-374345FD-3328-4F33-8199-8A3929853321

Q33780866-467C08C4-C833-42F9-8DDB-6AFE4E5F795F

Q33780866-4E211E25-7E74-4FBD-890E-69040A5E3204

P304

Q33780866-489A5DC5-8CB1-4BD7-890C-8CD6FF6DEC1F

P31

Q33780866-7C8E5AE8-A5D3-4DAB-8C65-1D3B40EB9F97

P356

Q33780866-B72FD84E-83FF-4347-A30C-17326B608CFA

P433

Q33780866-87D13770-E51E-4498-A3D4-536077BC99B8

P478

Q33780866-4AAC4DE9-16BF-4E86-917E-ED6516F6FA09

P50

Q33780866-ED8BF51B-360C-4A8C-855F-0E2246930ACA

P577

Q33780866-5BA6D161-3CEF-4FA4-BB7E-27944852526F

P5875

Q33780866-A52E0BC5-079F-4EA3-8079-3F0D388BA37A

P698

Q33780866-B984B167-C68F-4EA3-8F6C-0343939A5318

P921

Q33780866-9B246735-F534-483F-A9F8-680058091D78

P932

Q33780866-11675ACE-52B6-45E9-A583-C63CD534C61D

P356

J.1365-2982.2009.01442.X

P1433

Neurogastroenterology and Motility

P1476

Lower functional gastrointesti ...... ansit in a 287 patient cohort.

@en

P2093

B S Wong

http://www.w3.org/2001/XMLSchema#string

D Burton

http://www.w3.org/2001/XMLSchema#string

M Camilleri

http://www.w3.org/2001/XMLSchema#string

N Manabe

http://www.w3.org/2001/XMLSchema#string

S McKinzie

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and Trends in Obesity Among US Adults, 1999-2000

Small intestinal bacterial overgrowth in patients with irritable bowel syndrome

Stool form scale as a useful guide to intestinal transit time

Symptoms and physiology in severe chronic constipation

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder.

Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans.

Motor function in irritable bowel syndrome.

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.

Defecation frequency and timing, and stool form in the general population: a prospective study.

Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health.

P304

293-e82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2982.2009.01442.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Alan R. Zinsmeister

P577

2009-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40756222

http://www.w3.org/2001/XMLSchema#string

P698

20025692

http://www.w3.org/2001/XMLSchema#string

P921

P932

2852497

http://www.w3.org/2001/XMLSchema#string